T-Y. Yang - Concepedia

Author

T-Y. Yang

Taichung Veterans General Hospital

Also Known As

T-Y Yang, T-Y. Yang

Publications

313

Citations

H-Index

Concepts

All Affiliations

Taichung Veterans General Hospital Seoul National University Hospital Asan Medical Center Dana-Farber Cancer Institute National Taiwan University Hospital

About

T-Y. Yang is an author at Taichung Veterans General Hospital specializing in medicine, molecular oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	128
2	Immunology	1	1	59
3	Molecular Medicine	1	1	10
4	Neurology	1	1	44
5	Orthopaedics	1	1	44

T-Y. Yang

Publications

275

Citations

H-Index

Page 1

	Year	Citations
The ERK–ZEB1 pathway mediates epithelial–mesenchymal transition in pemetrexed resistant lung cancer cells with suppression by vinca alkaloids Leo Kai‐Ming Chiu, I-L Hsin, T-Y. Yang, Oncogene	2016	109
LBA55 Trastuzumab deruxtecan (T-DXd) in patients (Pts) with HER2-mutant metastatic non-small cell lung cancer (NSCLC): Interim results from the phase 2 DESTINY-Lung02 trial Keiko Goto, K. Sang-We, Takafumi Kubo, Annals of Oncology Destiny-lung02 TrialMedicineImmunologyPathologyImmune Checkpoint Inhibitor	2022	59
The effects of an injury to the brain on bone healing and callus formation in young adults with fractures of the femoral shaft T-Y. Yang, T.-Y. Wang, Y-H. Tsai, Journal of Bone and Joint Surgery - British Volume Skeletal TraumaTraumatic Brain InjuryYoung AdultsMedicineSurgical Stabilization	2012	44
LncRNA SND1-IT1 accelerates the proliferation and migration of osteosarcoma via sponging miRNA-665 to upregulate POU2F1. X-M Jin, Bin Xu, Y Zhang, PubMed	2019	24
514MO Acquired mechanisms of resistance to first-line (1L) osimertinib with or without platinum-based chemotherapy (CT) in EGFR-mutated (EGFRm) advanced NSCLC: Preliminary data from FLAURA2 Chee Khoon Lee, Jacqulyne Robichaux, Pasi A. Jänne, Annals of Oncology MedicinePharmacologyAcquired MechanismsCancer Cell BiologyPathology	2023	15
Effect of electrochemical structuring of Ti6Al4V on osteoblast behaviour<i>in vitro</i> M.A. Birch, Sarah Johnson-Lynn, S. Nouraei, Biomedical Materials	2012	14
987P Sunvozertinib for NSCLC patients with EGFR exon 20 insertion mutations: Preliminary analysis of WU-KONG6, the first pivotal study Meng Wang, J.C-H. Yang, P. Mitchell, Annals of Oncology Insertion MutationsMedicineFirst Pivotal StudyPathologyMolecular Oncology	2022	10

Page 1